griseofulvin microsize

Generic: griseofulvin

Labeler: heritage pharmaceuticals inc d/b/a avet pharmaceuticals inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name griseofulvin microsize
Generic Name griseofulvin
Labeler heritage pharmaceuticals inc d/b/a avet pharmaceuticals inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

griseofulvin 500 mg/1

Manufacturer
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc

Identifiers & Regulatory

Product NDC 23155-865
Product ID 23155-865_d6360b00-96f1-4508-82e8-8425f8393851
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA060569
Listing Expiration 2026-12-31
Marketing Start 2023-06-30

Pharmacologic Class

Established (EPC)
tubulin inhibiting agent [epc]
Physiologic Effect
decreased mitosis [pe] microtubule inhibition [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 23155865
Hyphenated Format 23155-865

Supplemental Identifiers

RxCUI
310600
UNII
32HRV3E3D5
NUI
N0000008732 N0000175085 N0000175848

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name griseofulvin microsize (source: ndc)
Generic Name griseofulvin (source: ndc)
Application Number ANDA060569 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE, PLASTIC (23155-865-01)
source: ndc

Packages (1)

23155-865-01 100 TABLET in 1 BOTTLE, PLASTIC (23155-865-01)

Ingredients (1)

griseofulvin (500 mg/1)

Linked Drug Pages (1)

GRISEOFULVIN MICROSIZE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d6360b00-96f1-4508-82e8-8425f8393851", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "unii": ["32HRV3E3D5"], "rxcui": ["310600"], "spl_set_id": ["1c26d7a6-17d9-4a95-a4ee-cfc5fe6bb95d"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (23155-865-01)", "package_ndc": "23155-865-01", "marketing_start_date": "20230630"}], "brand_name": "GRISEOFULVIN MICROSIZE", "product_id": "23155-865_d6360b00-96f1-4508-82e8-8425f8393851", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "23155-865", "generic_name": "griseofulvin", "labeler_name": "Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GRISEOFULVIN MICROSIZE", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "500 mg/1"}], "application_number": "ANDA060569", "marketing_category": "ANDA", "marketing_start_date": "20230630", "listing_expiration_date": "20261231"}